Ho Jung An

5PUBLICATIONS
56CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designHuman rights and justice issues (excl. law)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

In-Ho Kim, Seung Joo Kang, Wonyoung Choi

|May 02, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation.

Guk Jin Lee, Hyunho Kim, Sung Shim Cho

|Jul 12, 2022
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11).

Hyun Ae Jung, Keon-Uk Park, Sanghee Cho

|Jul 14, 2019
Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial.

J H Lee, H J Ju, H S Kwon

|Feb 06, 2015
Experience of advance directives in a hospice center.

Bong Han Kong, Ho Jung An, Hyun Seon Kim

Pageof 1

Frequent Collaborators

2 joint publications

In-Ho Kim

1 joint publications

J H Lee

1 joint publications

J M Bae

1 joint publications

Bong Han Kong